You have 9 free searches left this month | for more free features.

Chronic inflammatory demyelinating polyradiculoneuropathy

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pediatric Chronic Inflammatory Demyelinating Polyneuropathy Trial (Panzyga)

Not yet recruiting
  • Pediatric Chronic Inflammatory Demyelinating Polyneuropathy
  • (no location specified)
Sep 2, 2022

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Rozzano (Rituximab)

Active, not recruiting
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
  • Rozzano, Milano, Italy
    Istituto Clinico Humanitas
May 17, 2023

GAMMAGARD LIQUID in Chronic Inflammatory Demyelinating

Active, not recruiting
  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
    • Durham, North Carolina
      RTI Health Solutions
    Jun 14, 2022

    Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Multifocal Motor Neuropathy (MMN) Trial in Japan (TAK-771)

    Recruiting
    • Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
    • Multifocal Motor Neuropathy (MMN)
    • Nagoya, Aichi, Japan
    • +16 more
    Feb 2, 2023

    Intravenous Immunoglobulin Treatment in Chronic Inflammatory

    Completed
    • Chronic Inflammatory Demyelinating Polyradiculoneuropathy
      • Paris, France
        Groupe Hospitalier Paris Saint-Joseph
      Mar 30, 2022

      Peripheral Neuropathy, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Vasculitic Neuropathy (Disorder) Trial in

      Active, not recruiting
      • Peripheral Neuropathy
      • +5 more
      • Biopsy + Nerve Repair
      • Biopsy Only
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 25, 2023

      Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Trial in Worldwide (Rozanolixizumab)

      Completed
      • Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
      • Scottsdale, Arizona
      • +13 more
      Mar 31, 2022

      Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Neuromyelitis Optica Spectrum Disorder Trial in Wuhan (CT103A

      Recruiting
      • Autoimmune Diseases
      • +5 more
      • CT103A cells
      • Cyclophosphamide and fludarabine
      • Wuhan, Hubei, China
        Tongji Hospital affiliated to Tongji Medical College of Huazhong
      Dec 10, 2022

      Disease Activity in Chronic Inflammatory Demyelinating

      Recruiting
      • CIDP
      • Smartwatch (Withings Scanwatch)
      • Duesseldorf, Northrhine-Westphalia, Germany
        Medical Faculty, Heinrich-Heine-University
      Feb 1, 2023

      RWE-based Treatment Patterns and Outcomes in CIDP

      Not yet recruiting
      • Chronic Inflammatory Demyelinating Polyneuropathy
      • +2 more
      • No intervention. Retrospective observation only.
      • Salford, United Kingdom
        Northern Care Alliance NHS Foundation Trust
      Jul 7, 2023

      Chronic Inflammatory Demyelinating Polyneuropathy Trial in Atlanta (VitalStim 400, VitalStim400)

      Recruiting
      • Chronic Inflammatory Demyelinating Polyneuropathy
      • VitalStim 400
      • VitalStim400
      • Atlanta, Georgia
        Center for Advanced Pediatrics, Children's Healthcare of Atlanta
      Sep 2, 2022

      Predict Intravenous Immunoglobulin Responders in Chronic

      Suspended
      • CIDP
      • CIDP treated (IVIG)
      • Bordeaux, Aquitaine, France
      • +17 more
      Dec 23, 2021

      High Frequency Ultrasound in Demyelinating Polyneuropathies

      Not yet recruiting
      • Chronic Inflammatory Demyelinating Polyradiculoneuropathy
      • high frequency ultrasound
      • Nice, France
        Nice University Hospital
      Jul 28, 2021

      Spinal Cord Injuries Trial in Sugar Land (HB-adMSCs)

      No longer available
      • Chronic Inflammatory Demyelinating Polyneuropathy
      • HB-adMSCs
      • Sugar Land, Texas
        Hope Biosciences Stem Cell Research Foundation
      Sep 20, 2022

      Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Trial (Clinical examination, Functional scales, Walking test)

      Not yet recruiting
      • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
      • Clinical examination
      • +2 more
      • (no location specified)
      Aug 5, 2022

      Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Nice (Ultrasound UHF peripheral nerves, Electro myography

      Completed
      • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
      • Ultrasound UHF peripheral nerves
      • Electro myography surface nerves
      • Nice, France
        CHU de Nice
      May 5, 2022

      Polyneuropathy, Impairments and Physical Activity - The

      Not yet recruiting
      • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
      • +8 more
      • Validity and reliability of outcome measures in polyneuropathy
      • Healthy controls
      • (no location specified)
      Sep 15, 2023

      Chronic Inflammatory Demyelinating Polyneuropathy Trial in Boca Raton, Austin (Batoclimab 680 milligrams (mg) subcutaneous (SC)

      Recruiting
      • Chronic Inflammatory Demyelinating Polyneuropathy
      • Batoclimab 680 milligrams (mg) subcutaneous (SC) weekly
      • +2 more
      • Boca Raton, Florida
      • +1 more
      Jan 31, 2023

      Chronic Inflammatory Demyelinating Polyradiculoneuropathy Trial in Worldwide (SAR445088 (IV), SAR445088 (SC))

      Recruiting
      • Chronic Inflammatory Demyelinating Polyradiculoneuropathy
      • SAR445088 (IV)
      • SAR445088 (SC)
      • Los Angeles, California
      • +28 more
      Aug 24, 2022

      Clinical and Electrophysiological Patterns of Chronic Dysimmune

      Not yet recruiting
      • Chronic Inflammatory Demyelinating Polyneuropathy
        • (no location specified)
        Jan 20, 2022

        Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Trial in Japan (Rituximab (genetical recombination), Placebo)

        Completed
        • Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
        • Rituximab (genetical recombination)
        • Placebo
        • Nagoya, Aich, Japan
        • +3 more
        Aug 19, 2021

        CIDP, Immunoglobulin Deficiency, Chronic Inflammatory Demyelinating Polyneuropathy Trial in New Brunswick (Intravenous immune

        Recruiting
        • CIDP
        • +2 more
        • Intravenous immune globulin G
        • Subcutaneous immune globulin G
        • New Brunswick, New Jersey
          Rutgers, The State University of New Jersey Clinical Research Ce
        Oct 13, 2022

        Chronic Inflammatory Demyelinating Polyneuropathy Trial (Cyclophosphamide)

        Withdrawn
        • Chronic Inflammatory Demyelinating Polyneuropathy
        • (no location specified)
        Nov 2, 2021

        Chronic Inflammatory Demyelinating Polyradiculoneuropathy Trial in Worldwide (HYQVIA)

        Active, not recruiting
        • Chronic Inflammatory Demyelinating Polyradiculoneuropathy
        • HYQVIA
        • Phoenix, Arizona
        • +34 more
        Mar 21, 2022

        Healthy, Primary Immune Thrombocytopenia, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Worldwide

        Recruiting
        • Healthy
        • +2 more
        • PF-06755347 intravenous healthy participant
        • +4 more
        • New Haven, Connecticut
        • +5 more
        Dec 29, 2022